每一個人的細胞都擁有23組染色體,由長度大至小以作分類,最長的為第1組,最尾的一組為XY性別染色體,XX染色體為女性,XY染色體為男性。1327Please respect copyright.PENANAxEy1dgPooA
1327Please respect copyright.PENANA4Dx0lP6BJh
大概喺1950左右,一名叫Peter Nowell的科學家認為染色體的變異係造就癌症的主因,所以決定醉心研究癌症病人的染色體變化。1327Please respect copyright.PENANAv6kw8G5AAB
最後,他與一名叫David Hungerford發現,某類血癌病人的染色體有著一款非常標誌性的變異。1327Please respect copyright.PENANAwfY4q4DiNc
1327Please respect copyright.PENANAPlAIajyeBi
基於他們當時在費城發現到依個現象,所以就決定將嗰條異變染色體命名為費城染色體。(有時候,科學家的想法總是令人難以理解)1327Please respect copyright.PENANAgovjK2dglm
1327Please respect copyright.PENANAIg6La4cPgy
直到1973年,研究染色體的技術開始有所增長,科學家發現費城染色體其實係一條較正常為短小的22染色體,因為基因突變而與第9染色體有所交換。(圖1、2)1327Please respect copyright.PENANANkGE9PhMxb
1327Please respect copyright.PENANAQsgyLnFK14
1327Please respect copyright.PENANA06fjf0vDYP
1327Please respect copyright.PENANAdQ8CCto8GH
科學家繼續研究,終於在1990年發現,費城染色體會導致白血球產生一隻名為bcr-abl的異常蛋白質(之所以會如此命名,係因為第9染色體負責製造bcr蛋白質的部份與第22染色體負責製造abl蛋白質的部份合埋在一齊)。1327Please respect copyright.PENANApVcypqGll0
1327Please respect copyright.PENANAaOTG7wCJdV
(圖3)依隻bcr-abl異常蛋白質會導致白血球無止境咁增長,形成醫學上名為CML的疾病(Chronic Myeloid Leukemia,慢性骨髓白血病),為血癌的一種,確診5年後的存活率平均為30%。1327Please respect copyright.PENANADGZM9F6a2p
1327Please respect copyright.PENANAfdP0RyCspJ
1327Please respect copyright.PENANAMVPuGhXLE4
而在科學家們的努力研究下,他們成功製作出一隻口服藥物Gleevec,能有效黏住及抑制bcr-abl的效果,令白血球數量回復正常水平;1327Please respect copyright.PENANArp2Hk0ikXH
有唔少病人可能要終生服用藥物來抑制bcr-abl變異蛋白質,但亦有例子在長年服用後可以斷尾或減低服量。1327Please respect copyright.PENANA6rrGXaiUbb
1327Please respect copyright.PENANAkCnUuQAR72
這藥物最終在2001年被美國FDA認可,大幅度將病人確診5年後的存活率由30%升至89%。1327Please respect copyright.PENANAaryzUjvj02
1327Please respect copyright.PENANASbnGC6VbuC
CML在病理學上大概可以分成為三個階段,越早發現及醫治的話,藥物的效果便會越有效。1327Please respect copyright.PENANAY2mq0dTqgW
而直至現今,科學家已經至少再研發咗兩款對付CML的藥物,若果病人對Gleevec呈抗藥性的話,他們還有至少兩款藥物可以用作治療。1327Please respect copyright.PENANA6EVdvLJiOU
1327Please respect copyright.PENANA081I3ZcBB6
1327Please respect copyright.PENANA2Su51h102a
由1950年及1973年的染色體變異發現、1990年的機制發現,直至2001年藥物研發及對病人帶正面治療效果,整個過程差不多歷時50年有多。1327Please respect copyright.PENANA1rMkfO5RCG
這隻藥物的誕生和成功,無疑為癌症研究領域上立下一個重要里程碑,亦同時向大眾說明了科學是有能力可以對付癌症的。1327Please respect copyright.PENANAj17nuOyYax
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline Info
-
toc Table of Contents
-
share Share
-
format_color_text Display Settings
-
exposure_plus_1 Recommend
-
Sponsor
-
report_problem Report
-
account_circle Login
Search stories, writers or societies
Continue ReadingClear All
What Others Are ReadingRefresh
X
Never miss what's happening on Penana!
科普專欄–薯不揀單
Author:
薯仔聞茱莉
ISSUE #17
<<深入淺出-費城染色體>>
LIKES 2
READS 1323
BOOKMARKS 151
campaign
Request update 0
Sponsor
Login with Facebook
or Sign up/Login to comment or bookmark! Click to load the next chapter
X
After each update request, the author will receive a notification!
smartphone100
→ Request update
X
Sponsor again
Click to login
Login first to show your name as a sponsor.
Thank you for supporting the story! :)
Please Login first.
×
Write down what you like about the story
×
Reading Theme:
Font Size:
Line Spacing:
Paragraph Spacing:
Load the next issue automatically
Reset to default
×
People Who Like This
x
Before You Publish
Please ensure your story does not contain illegal, hateful, inciting, or violence-promoting content, or any infringing, plagiarized, or spam material, and that it complies with Penana’s Terms of Use.
Penana reserves the right to remove any content that violates these rules or causes legal or community risk, and to suspend or terminate related accounts.

